Chemokines in vascular remodeling.

Area of Science:

• Cardiovascular Biology
• Immunology
• Cell Biology

Background:

• Arterial injuries trigger structural changes leading to luminal narrowing and disease progression.
• Vascular remodeling involves neointima formation, medial thickening, inflammation, and endothelial dysfunction.
• Chemokines and their receptors play critical roles throughout the vascular remodeling process.

Purpose of the Study:

• To elucidate the specific roles of various chemokine axes in vascular remodeling.
• To understand the contribution of chemokines to processes like neointima formation and cell recruitment.
• To highlight the potential for therapeutic targeting of the chemokine network in vascular diseases.

Main Methods:

• Analysis of chemokine and receptor involvement in established models of vascular injury.
• Investigation of specific chemokine axes such as MCP-1/CCR2, SDF-1α/CXCR4, RANTES/CCR1/CCR5, fractalkine, and CXCL1.
• Examination of cellular responses including monocyte infiltration, smooth muscle cell proliferation, and progenitor cell recruitment.

Main Results:

• The MCP-1/CCR2 axis drives monocyte infiltration and smooth muscle cell proliferation in various hypertensive and vasculopathy models.
• SDF-1α/CXCR4 is crucial for recruiting smooth muscle cell progenitor cells, potentially linked to smooth muscle cell apoptosis.
• RANTES receptors (CCR1, CCR5) influence monocyte infiltration and neointimal growth, while fractalkine mediates monocyte arrest.
• CXCL1 appears essential for reendothelialization of injured vessels.

Conclusions:

• Chemokine signaling forms a complex network regulating diverse aspects of vascular remodeling.
• Targeting specific components of the chemokine network presents a promising strategy for therapeutic intervention in vascular diseases.